RITONAVIR PHARMACOPOEIA européenne (EP) R

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Ritonavir may be used as a pharmaceutical primary standard for the quantification of the analyte in pharmaceutical formulations using chromatography techniques.

Caution

Please find SDS provided by EDQM here..

General description

Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.

Other Notes

Sales restrictions may apply.

Packaging

Unit quantity: 80 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.